Advances in Hydrogel-Based Delivery of RNA Drugs for Antitumor Therapy
Gels · 11.08.2025 · 11 (8) · 633
DOI: 10.3390/gels11080633 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Gels, online erschienen am 11.08.2025. Verfasst von Hui Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Anhui Medical University, Hefei 230032, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Pharmaceutical Summit Discipline Fund of Anhui Medical University, Pharmaceutical Summit Discipline Fund of Anhui Medical University.
Abstract (Originalsprache)
Tumors are a major disease that seriously threatens human health, with their incidence and mortality rates increasing year by year. However, traditional therapies such as surgery, chemotherapy, and radiotherapy have significant limitations, including significant side effects and propensity for drug resistance. In recent years, with the rapid development of medical technology, RNA therapy has shown great potential as an emerging treatment method in anti-tumor therapy, bringing new hope for tumor treatment. RNA therapy mainly includes small interfering RNA, antisense oligonucleotides, and aptamers. Hydrogels, as a polymer material with three-dimensional network structure, have good biocompatibility and can effectively improve the efficiency of RNA delivery. This review specifically focuses on the application of hydrogels as RNA carriers in anti-tumor therapy, along with the classification, delivery advantages, and challenges. However, despite existing deficiencies in safety and targeting, hydrogel-mediated RNA delivery for tumor treatment still shows unique advantages and broad application prospects. In the future, research and cutting-edge innovations are expected to facilitate precision oncology solutions, offering superior treatment options and catalyzing the evolution of cancer management strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Anhui Medical University, Hefei 230032, China.
Förderung
- the Pharmaceutical Summit Discipline Fund of Anhui Medical University
- Pharmaceutical Summit Discipline Fund of Anhui Medical University
Zitieren
APA
Xu, H., Fei, Y., Wang, X., Jiao, W., & Jin, Y. (2025). Advances in Hydrogel-Based Delivery of RNA Drugs for Antitumor Therapy. Gels, 11(8), 633. https://doi.org/10.3390/gels11080633
Vancouver
Xu H, Fei Y, Wang X, Jiao W, Jin Y. Advances in Hydrogel-Based Delivery of RNA Drugs for Antitumor Therapy. Gels. 2025;11(8):633. doi:10.3390/gels11080633
BibTeX
@article{Xu2025,
author = {Xu, Hui and Fei, Yang and Wang, Xueya and Jiao, Wenfeng and Jin, Yong},
title = {Advances in Hydrogel-Based Delivery of RNA Drugs for Antitumor Therapy},
journal = {Gels},
year = {2025},
volume = {11},
number = {8},
pages = {633},
doi = {10.3390/gels11080633}
}
EUVIMED